 | • レポートコード：20QY06-05079 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、凝固因子IXのグローバル市場について種類別（凝固因子IX（血漿由来）、凝固因子IX（組換え））、用途別（大人、子供）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・凝固因子IX市場の概要 ・世界の主要地域別凝固因子IX市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の凝固因子IX市場規模2015-2026：種類別（凝固因子IX（血漿由来）、凝固因子IX（組換え）） ・世界の凝固因子IX市場規模2015-2026：用途別（大人、子供） ・凝固因子IXの北米市場規模2015-2020 ・凝固因子IXのヨーロッパ市場規模2015-2020 ・凝固因子IXの中国市場規模2015-2020 ・凝固因子IXの日本市場規模2015-2020 ・凝固因子IXの東南アジア市場規模2015-2020 ・凝固因子IXのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Pfizer、CSL Behring、Grifols、Novo Nordisk、Bioverativ、Sanquin、Takeda、Baxter、Aptevo） ・凝固因子IXの製造コスト分析 ・販売チャネル、流通業者、顧客 ・凝固因子IXの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Coagulation Factor IX Market
The global Coagulation Factor IX market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Coagulation Factor IX Scope and Market Size
The global Coagulation Factor IX market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Coagulation Factor IX market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Coagulation Factor IX market is segmented into
Coagulation Factor IX (Plasma Derived)
Coagulation Factor IX (Recombinant)
Segment by Application, the Coagulation Factor IX market is segmented into
Adult
Kids
The Coagulation Factor IX market is analysed and market size information is provided by regions (countries). Segment by Application, the Coagulation Factor IX market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Coagulation Factor IX Market Share Analysis
Coagulation Factor IX market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Coagulation Factor IX business, the date to enter into the Coagulation Factor IX market, Coagulation Factor IX product introduction, recent developments, etc.
The major vendors covered:
Pfizer
CSL Behring
Grifols
Novo Nordisk
Bioverativ
Sanquin
Takeda
Baxter
Aptevo
Table of Contents
1 Coagulation Factor IX Market Overview
1.1 Coagulation Factor IX Product Scope
1.2 Coagulation Factor IX Segment by Type
1.2.1 Global Coagulation Factor IX Sales by Type (2020-2026)
1.2.2 Coagulation Factor IX (Plasma Derived)
1.2.3 Coagulation Factor IX (Recombinant)
1.3 Coagulation Factor IX Segment by Application
1.3.1 Global Coagulation Factor IX Sales Comparison by Application (2020-2026)
1.3.2 Adult
1.3.3 Kids
1.4 Coagulation Factor IX Market Estimates and Forecasts (2015-2026)
1.4.1 Global Coagulation Factor IX Sales Growth Rate (2015-2026)
1.4.2 Global Coagulation Factor IX Revenue and Growth Rate (2015-2026)
1.4.3 Global Coagulation Factor IX Price Trends (2015-2026)
2 Coagulation Factor IX Estimate and Forecast by Region
2.1 Global Coagulation Factor IX Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Coagulation Factor IX Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Coagulation Factor IX Sales Market Share by Region (2015-2020)
2.2.2 Global Coagulation Factor IX Revenue Market Share by Region (2015-2020)
2.3 Global Coagulation Factor IX Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Coagulation Factor IX Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Coagulation Factor IX Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Coagulation Factor IX Estimates and Projections (2015-2026)
2.4.2 Europe Coagulation Factor IX Estimates and Projections (2015-2026)
2.4.3 China Coagulation Factor IX Estimates and Projections (2015-2026)
2.4.4 Japan Coagulation Factor IX Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Coagulation Factor IX Estimates and Projections (2015-2026)
2.4.6 India Coagulation Factor IX Estimates and Projections (2015-2026)
3 Global Coagulation Factor IX Competition Landscape by Players
3.1 Global Top Coagulation Factor IX Players by Sales (2015-2020)
3.2 Global Top Coagulation Factor IX Players by Revenue (2015-2020)
3.3 Global Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Coagulation Factor IX as of 2019)
3.4 Global Coagulation Factor IX Average Price by Company (2015-2020)
3.5 Manufacturers Coagulation Factor IX Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Coagulation Factor IX Players (Opinion Leaders)
4 Global Coagulation Factor IX Market Size by Type
4.1 Global Coagulation Factor IX Historic Market Review by Type (2015-2020)
4.1.1 Global Coagulation Factor IX Sales Market Share by Type (2015-2020)
4.1.2 Global Coagulation Factor IX Revenue Market Share by Type (2015-2020)
4.1.3 Global Coagulation Factor IX Price by Type (2014-2020)
4.2 Global Coagulation Factor IX Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Coagulation Factor IX Sales Forecast by Type (2021-2026)
4.2.2 Global Coagulation Factor IX Revenue Forecast by Type (2021-2026)
4.2.3 Global Coagulation Factor IX Price Forecast by Type (2021-2026)
5 Global Coagulation Factor IX Market Size by Application
5.1 Global Coagulation Factor IX Historic Market Review by Application (2015-2020)
5.1.1 Global Coagulation Factor IX Sales Market Share by Application (2015-2020)
5.1.2 Global Coagulation Factor IX Revenue Market Share by Application (2015-2020)
5.1.3 Global Coagulation Factor IX Price by Application (2015-2020)
5.2 Global Coagulation Factor IX Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Coagulation Factor IX Sales Forecast by Application (2021-2026)
5.2.2 Global Coagulation Factor IX Revenue Forecast by Application (2021-2026)
5.2.3 Global Coagulation Factor IX Price Forecast by Application (2021-2026)
3 North America Coagulation Factor IX Market Facts & Figures
3.2 North America Coagulation Factor IX Sales Market Share by Company (2015-2020)
3.3 North America Coagulation Factor IX Sales Market Share by Type (2015-2020)
3.4 North America Coagulation Factor IX Sales Market Share by Application (2015-2020)
4 Europe Coagulation Factor IX Market Facts & Figures
4.2 Europe Coagulation Factor IX Sales Market Share by Company (2015-2020)
4.3 Europe Coagulation Factor IX Sales Market Share by Type (2015-2020)
4.4 Europe Coagulation Factor IX Sales Market Share by Application (2015-2020)
5 China Coagulation Factor IX Market Facts & Figures
5.2 China Coagulation Factor IX Sales Market Share by Company (2015-2020)
5.3 China Coagulation Factor IX Sales Market Share by Type (2015-2020)
5.4 China Coagulation Factor IX Sales Market Share by Application (2015-2020)
6 Japan Coagulation Factor IX Market Facts & Figures
6.2 Japan Coagulation Factor IX Sales Market Share by Company (2015-2020)
6.3 Japan Coagulation Factor IX Sales Market Share by Type (2015-2020)
6.4 Japan Coagulation Factor IX Sales Market Share by Application (2015-2020)
7 Southeast Asia Coagulation Factor IX Market Facts & Figures
7.2 Southeast Asia Coagulation Factor IX Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Coagulation Factor IX Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Coagulation Factor IX Sales Market Share by Application (2015-2020)
8 India Coagulation Factor IX Market Facts & Figures
8.2 India Coagulation Factor IX Sales Market Share by Company (2015-2020)
8.3 India Coagulation Factor IX Sales Market Share by Type (2015-2020)
8.4 India Coagulation Factor IX Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Coagulation Factor IX Business
12.1 Pfizer
12.1.1 Pfizer Coagulation Factor IX Corporation Information
12.1.2 Pfizer Coagulation Factor IX Business Overview and Total Revenue
12.1.3 Pfizer Coagulation Factor IX Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Coagulation Factor IX Products Offered
12.1.5 Pfizer Recent Development
12.2 CSL Behring
12.2.1 CSL Behring Coagulation Factor IX Corporation Information
12.2.2 CSL Behring Coagulation Factor IX Business Overview and Total Revenue
12.2.3 CSL Behring Coagulation Factor IX Sales, Revenue and Gross Margin (2015-2020)
12.2.4 CSL Behring Coagulation Factor IX Products Offered
12.2.5 CSL Behring Recent Development
12.3 Grifols
12.3.1 Grifols Coagulation Factor IX Corporation Information
12.3.2 Grifols Coagulation Factor IX Business Overview and Total Revenue
12.3.3 Grifols Coagulation Factor IX Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Grifols Coagulation Factor IX Products Offered
12.3.5 Grifols Recent Development
12.4 Novo Nordisk
12.4.1 Novo Nordisk Coagulation Factor IX Corporation Information
12.4.2 Novo Nordisk Coagulation Factor IX Business Overview and Total Revenue
12.4.3 Novo Nordisk Coagulation Factor IX Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novo Nordisk Coagulation Factor IX Products Offered
12.4.5 Novo Nordisk Recent Development
12.5 Bioverativ
12.5.1 Bioverativ Coagulation Factor IX Corporation Information
12.5.2 Bioverativ Coagulation Factor IX Business Overview and Total Revenue
12.5.3 Bioverativ Coagulation Factor IX Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bioverativ Coagulation Factor IX Products Offered
12.5.5 Bioverativ Recent Development
12.6 Sanquin
12.6.1 Sanquin Coagulation Factor IX Corporation Information
12.6.2 Sanquin Coagulation Factor IX Business Overview and Total Revenue
12.6.3 Sanquin Coagulation Factor IX Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sanquin Coagulation Factor IX Products Offered
12.6.5 Sanquin Recent Development
12.7 Takeda
12.7.1 Takeda Coagulation Factor IX Corporation Information
12.7.2 Takeda Coagulation Factor IX Business Overview and Total Revenue
12.7.3 Takeda Coagulation Factor IX Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Takeda Coagulation Factor IX Products Offered
12.7.5 Takeda Recent Development
12.8 Baxter
12.8.1 Baxter Coagulation Factor IX Corporation Information
12.8.2 Baxter Coagulation Factor IX Business Overview and Total Revenue
12.8.3 Baxter Coagulation Factor IX Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Baxter Coagulation Factor IX Products Offered
12.8.5 Baxter Recent Development
12.9 Aptevo
12.9.1 Aptevo Coagulation Factor IX Corporation Information
12.9.2 Aptevo Coagulation Factor IX Business Overview and Total Revenue
12.9.3 Aptevo Coagulation Factor IX Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Aptevo Coagulation Factor IX Products Offered
12.9.5 Aptevo Recent Development
13 Coagulation Factor IX Manufacturing Cost Analysis
13.1 Coagulation Factor IX Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Coagulation Factor IX
13.4 Coagulation Factor IX Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Coagulation Factor IX Distributors List
14.3 Coagulation Factor IX Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Coagulation Factor IX Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Coagulation Factor IX Sales (K Units) Comparison by Application (2020-2026)
Table 3. Global Market Coagulation Factor IX Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Coagulation Factor IX Sales (K Units) by Region (2015-2020)
Table 5. Global Coagulation Factor IX Sales Market Share by Region (2015-2020)
Table 6. Global Coagulation Factor IX Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Coagulation Factor IX Revenue Share by Region (2015-2020)
Table 8. Global Coagulation Factor IX Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Coagulation Factor IX Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Coagulation Factor IX Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Coagulation Factor IX Revenue Share Forecast by Region (2021-2026)
Table 12. Global Coagulation Factor IX (K Units) of Key Companies (2015-2020)
Table 13. Global Coagulation Factor IX Sales Share by Company (2015-2020)
Table 14. Global Coagulation Factor IX Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Coagulation Factor IX Revenue Share by Company (2015-2020)
Table 16. Global Coagulation Factor IX by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Coagulation Factor IX as of 2019)
Table 17. Global Coagulation Factor IX Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Coagulation Factor IX Manufacturing Sites and Area Served
Table 19. Manufacturers Coagulation Factor IX Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Coagulation Factor IX Players
Table 22. Global Coagulation Factor IX Sales (K Units) by Type (2015-2020)
Table 23. Global Coagulation Factor IX Sales Share by Type (2015-2020)
Table 24. Global Coagulation Factor IX Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Coagulation Factor IX Price (K Units) by Type (2015-2020)
Table 26. Global Coagulation Factor IX Sales Share by Type (2021-2026)
Table 27. Global Coagulation Factor IX Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Coagulation Factor IX Revenue Share by Type (2021-2026)
Table 29. Global Coagulation Factor IX Price (K Units) by Type (2021-2026)
Table 30. Global Coagulation Factor IX Sales (K Units) by Application (2015-2020)
Table 31. Global Coagulation Factor IX Sales Share by Application (2015-2020)
Table 32. Global Coagulation Factor IX Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Coagulation Factor IX Price (K Units) by Application (2015-2020)
Table 34. Global Coagulation Factor IX Sales (K Units) by Application (2021-2026)
Table 35. Global Coagulation Factor IX Sales Share by Application (2021-2026)
Table 36. Global Coagulation Factor IX Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Coagulation Factor IX Revenue Share by Application (2021-2026)
Table 38. Global Coagulation Factor IX Price (K Units) by Application (2021-2026)
Table 39. United States Coagulation Factor IX Sales (K Units) by Company (2015-2020)
Table 40. United States Coagulation Factor IX Sales Market Share by Company (2015-2020)
Table 41. United States Coagulation Factor IX Sales (K Units) by Type (2015-2020)
Table 42. United States Coagulation Factor IX Sales Market Share by Type (2015-2020)
Table 43. United States Coagulation Factor IX Sales (K Units) by Application (2015-2020)
Table 44. United States Coagulation Factor IX Sales Market Share by Application (2015-2020)
Table 45. Europe Coagulation Factor IX Sales (K Units) by Company (2015-2020)
Table 46. Europe Coagulation Factor IX Sales Market Share by Company (2015-2020)
Table 47. Europe Coagulation Factor IX Sales (K Units) by Type (2015-2020)
Table 48. Europe Coagulation Factor IX Sales Market Share by Type (2015-2020)
Table 49. Europe Coagulation Factor IX Sales (K Units) by Application (2015-2020)
Table 50. Europe Coagulation Factor IX Sales Market Share by Type (2015-2020)
Table 51. China Coagulation Factor IX Sales (K Units) by Company (2015-2020)
Table 52. China Coagulation Factor IX Sales Market Share by Company (2015-2020)
Table 53. China Coagulation Factor IX Sales (K Units) by Type (2015-2020)
Table 54. China Coagulation Factor IX Sales Market Share by Type (2015-2020)
Table 55. China Coagulation Factor IX Sales (K Units) by Application (2015-2020)
Table 56. China Coagulation Factor IX Sales Market Share by Application (2015-2020)
Table 57. Japan Coagulation Factor IX Sales (K Units) by Company (2015-2020)
Table 58. Japan Coagulation Factor IX Sales Market Share by Company (2015-2020)
Table 59. Japan Coagulation Factor IX Sales (K Units) by Type (2015-2020)
Table 60. Japan Coagulation Factor IX Sales Market Share by Type (2015-2020)
Table 61. Japan Coagulation Factor IX Sales (K Units) by Application (2015-2020)
Table 62. Japan Coagulation Factor IX Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Coagulation Factor IX Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Coagulation Factor IX Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Coagulation Factor IX Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Coagulation Factor IX Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Coagulation Factor IX Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Coagulation Factor IX Sales Market Share by Application (2015-2020)
Table 69. India Coagulation Factor IX Sales (K Units) by Company (2015-2020)
Table 70. India Coagulation Factor IX Sales Market Share by Company (2015-2020)
Table 71. India Coagulation Factor IX Sales (K Units) by Type (2015-2020)
Table 72. India Coagulation Factor IX Sales Market Share by Type (2015-2020)
Table 73. India Coagulation Factor IX Sales (K Units) by Application (2015-2020)
Table 74. India Coagulation Factor IX Sales Market Share by Application (2015-2020)
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Coagulation Factor IX Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Pfizer Coagulation Factor IX Product
Table 79. Pfizer Recent Development
Table 80. CSL Behring Corporation Information
Table 81. CSL Behring Description and Business Overview
Table 82. CSL Behring Coagulation Factor IX Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. CSL Behring Coagulation Factor IX Product
Table 84. CSL Behring Recent Development
Table 85. Grifols Corporation Information
Table 86. Grifols Description and Business Overview
Table 87. Grifols Coagulation Factor IX Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Grifols Coagulation Factor IX Product
Table 89. Grifols Recent Development
Table 90. Novo Nordisk Corporation Information
Table 91. Novo Nordisk Description and Business Overview
Table 92. Novo Nordisk Coagulation Factor IX Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Novo Nordisk Coagulation Factor IX Product
Table 94. Novo Nordisk Recent Development
Table 95. Bioverativ Corporation Information
Table 96. Bioverativ Description and Business Overview
Table 97. Bioverativ Coagulation Factor IX Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Bioverativ Coagulation Factor IX Product
Table 99. Bioverativ Recent Development
Table 100. Sanquin Corporation Information
Table 101. Sanquin Description and Business Overview
Table 102. Sanquin Coagulation Factor IX Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Sanquin Coagulation Factor IX Product
Table 104. Sanquin Recent Development
Table 105. Takeda Corporation Information
Table 106. Takeda Description and Business Overview
Table 107. Takeda Coagulation Factor IX Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Takeda Coagulation Factor IX Product
Table 109. Takeda Recent Development
Table 110. Baxter Corporation Information
Table 111. Baxter Coagulation Factor IX Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Baxter Description and Business Overview
Table 113. Baxter Coagulation Factor IX Product
Table 114. Baxter Recent Development
Table 115. Aptevo Corporation Information
Table 116. Aptevo Coagulation Factor IX Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Aptevo Description and Business Overview
Table 118. Aptevo Coagulation Factor IX Product
Table 119. Aptevo Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Coagulation Factor IX Distributors List
Table 123. Coagulation Factor IX Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Coagulation Factor IX Product Picture
Figure 2. Global Coagulation Factor IX Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Coagulation Factor IX Market Share by Application in 2020 & 2026
Figure 6. Adult Examples
Figure 7. Kids Examples
Figure 8. Global Coagulation Factor IX Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Coagulation Factor IX Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Coagulation Factor IX Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Coagulation Factor IX Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Coagulation Factor IX Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Coagulation Factor IX Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Coagulation Factor IX Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Coagulation Factor IX Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Coagulation Factor IX Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Coagulation Factor IX Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Coagulation Factor IX Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Coagulation Factor IX Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Coagulation Factor IX Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Coagulation Factor IX Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Coagulation Factor IX Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Coagulation Factor IX Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Coagulation Factor IX Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Coagulation Factor IX Players Market Share by Revenue in Coagulation Factor IX 2015 & 2019
Figure 26. Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Coagulation Factor IX Revenue Share by Type (2015-2020)
Figure 28. Global Coagulation Factor IX Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Coagulation Factor IX Revenue Share by Application (2015-2020)
Figure 30. Global Coagulation Factor IX Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Coagulation Factor IX Sales Market Share by Type in 2019
Figure 32. United States Coagulation Factor IX Sales Market Share by Type in 2019
Figure 33. Europe Coagulation Factor IX Sales Market Share by Company in 2019
Figure 34. Europe Coagulation Factor IX Sales Market Share by Type in 2019
Figure 35. Europe Coagulation Factor IX Sales Market Share by Application in 2019
Figure 36. China Coagulation Factor IX Sales Market Share by Company in 2019
Figure 37. China Coagulation Factor IX Sales Market Share by Type in 2019
Figure 38. China Coagulation Factor IX Sales Market Share by Application in 2019
Figure 39. Japan Coagulation Factor IX Sales Market Share by Company in 2019
Figure 40. Japan Coagulation Factor IX Sales Market Share by Type in 2019
Figure 41. Japan Coagulation Factor IX Sales Market Share by Application in 2019
Figure 42. Southeast Asia Coagulation Factor IX Sales Market Share by Company in 2019
Figure 43. Southeast Asia Coagulation Factor IX Sales Market Share by Type in 2019
Figure 44. Southeast Asia Coagulation Factor IX Sales Market Share by Application in 2019
Figure 45. India Coagulation Factor IX Sales Market Share by Company in 2019
Figure 46. India Coagulation Factor IX Sales Market Share by Type in 2019
Figure 47. India Coagulation Factor IX Sales Market Share by Application in 2019
Figure 48. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. CSL Behring Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Bioverativ Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Sanquin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Aptevo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Key Raw Materials Price Trend
Figure 58. Manufacturing Cost Structure of Coagulation Factor IX
Figure 59. Manufacturing Process Analysis of Coagulation Factor IX
Figure 60. Coagulation Factor IX Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Porter's Five Forces Analysis
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
凝固因子濃縮物の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Coagulation Factor Concentrate market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Coagulation Fa…- ヒト凝固第VIII因子の世界市場レポート2020 Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. North America is the largest consumption market of Human Coagulation Factor VIII, with sal…
- ヒト凝固因子Ⅷの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Coagulation Factor Ⅷ market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Human Coagulation …
- 凝固試薬の世界市場レポート2020 Market Analysis and Insights: Global Coagulation Reagent Market The global Coagulation Reagent market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Coagulation Reagent Scope and Market Size The global Coagulat…
- 凝固分析装置の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Coagulation Analyzers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.3% in the forecast period of 2020 to 2025 and will expected to reach USD 3361.4 million by 2025, from USD 2737.8 million in 2019. The Coagulation An…